Active Filter(s):
Details:
Institut Pasteur Korea has confirmed the effectiveness of AstraZeneca's ciclesonide in treating COVID-19 in a drug repositioning study by testing over 3,000 agents with infected cells.
Lead Product(s): Ciclesonide
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 28, 2020